Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 72851 - 72875 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	SLC16A10	117247	downregulated	Silicon Dioxide analog results in decreased expression of SLC16A10 mRNA	6q21	A24195
Silicon dioxide	Approved	SLC16A2	6567	upregulated	Silicon Dioxide results in increased expression of SLC16A2 mRNA	Xq13.2	A24196
Silicon dioxide	Approved	SLC16A3	9123	downregulated	Silicon Dioxide analog results in decreased expression of SLC16A3 mRNA	17q25.3	A24195
Silicon dioxide	Approved	SLC16A5	9121	downregulated	Silicon Dioxide results in decreased expression of SLC16A5 mRNA	17q25.1	A24196
Silicon dioxide	Approved	SLC16A6	9120	upregulated	Silicon Dioxide analog results in increased expression of SLC16A6 mRNA	17q24.2	A24195
Silicon dioxide	Approved	SLC16A7	9194	downregulated	Silicon Dioxide analog results in decreased expression of SLC16A7 mRNA	12q14.1	A24195
Silicon dioxide	Approved	SLC16A7	9194	downregulated	Silicon Dioxide results in decreased expression of SLC16A7 mRNA	12q14.1	A24197 A24196
Silicon dioxide	Approved	SLC17A1	6568	downregulated	Silicon Dioxide analog results in decreased expression of SLC17A1 mRNA	6p22.2	A24195
Silicon dioxide	Approved	SLC17A3	10786	downregulated	Silicon Dioxide analog results in decreased expression of SLC17A3 mRNA	6p22.2	A24195
Silicon dioxide	Approved	SLC19A2	10560	upregulated	Silicon Dioxide results in increased expression of SLC19A2 mRNA	1q24.2	A24196
Silicon dioxide	Approved	SLC1A1	6505	downregulated	Silicon Dioxide analog results in decreased expression of SLC1A1 mRNA	9p24.2	A24195
Silicon dioxide	Approved	SLC1A4	6509	downregulated	Silicon Dioxide results in decreased expression of SLC1A4 mRNA	2p14	A24196
Silicon dioxide	Approved	SLC1A7	6512	downregulated	Silicon Dioxide analog results in decreased expression of SLC1A7 mRNA	1p32.3	A24195
Silicon dioxide	Approved	SLC20A1	6574	upregulated	Silicon Dioxide analog results in increased expression of SLC20A1 mRNA	2q14.1	A24195
Silicon dioxide	Approved	SLC22A1	6580	upregulated	Silicon Dioxide analog results in increased expression of SLC22A1 mRNA	6q25.3	A24194
Silicon dioxide	Approved	SLC22A10	387775	upregulated	Silicon Dioxide analog results in increased expression of SLC22A10 mRNA	11q12.3	A24195
Silicon dioxide	Approved	SLC22A15	55356	downregulated	Silicon Dioxide analog results in decreased expression of SLC22A15 mRNA	1p13.1	A24195
Silicon dioxide	Approved	SLC22A17	51310	downregulated	Silicon Dioxide analog results in decreased expression of SLC22A17 mRNA	14q11.2	A24195
Silicon dioxide	Approved	SLC22A18	5002	downregulated	Silicon Dioxide analog results in decreased expression of SLC22A18 mRNA	11p15.4	A24195
Silicon dioxide	Approved	SLC22A3	6581	downregulated	Silicon Dioxide analog results in decreased expression of SLC22A3 mRNA	6q25.3	A24195
Silicon dioxide	Approved	SLC22A3	6581	upregulated	Silicon Dioxide analog results in increased expression of SLC22A3 mRNA	6q25.3	A24194
Silicon dioxide	Approved	SLC22A4	6583	upregulated	Silicon Dioxide analog results in increased expression of SLC22A4 mRNA	5q31.1	A24195
Silicon dioxide	Approved	SLC23A1	9963	downregulated	Silicon Dioxide analog results in decreased expression of SLC23A1 mRNA	5q31.2	A24195
Silicon dioxide	Approved	SLC23A2	9962	downregulated	Silicon Dioxide analog results in decreased expression of SLC23A2 mRNA	20p13	A24195
Silicon dioxide	Approved	SLC24A1	9187	downregulated	Silicon Dioxide results in decreased expression of SLC24A1 mRNA	15q22.31	A24196

Displaying entries 72851 - 72875 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability